微信直播

AME新书《乳腺癌》译者招募

Published at: 2015年第1卷第S1期

关键词:

近年来,乳腺癌的发病率在世界范围内呈上升趋势。据国家癌症中心和卫生部疾病预防控制局2012年公布的2009年乳腺癌发病数据显示:全国肿瘤登记地区乳腺癌发病率位居女性恶性肿瘤的第1位,女性乳腺癌发病率(粗率)全国合计为42.55/10万,城市为51.91/10万,农村为23.12/10万。世界卫生组织预测,到2025年癌症确诊病例将超过1900万例。可见,乳腺癌已成为当前社会的重大公共卫生问题,亦是威胁女性健康的“头号杀手”。

关于乳腺癌的发病原因,目前尚不完全清楚;有研究发现乳腺癌的发病存在一定的规律性,具有乳腺癌高危因素的女性容易患乳腺癌。所谓高危因素是指与乳腺癌发病有关的各种危险因素,而大多数乳腺癌患者都具有的危险因素就称为乳腺癌的高危因素。且乳腺癌的预后依癌症的类型、癌症分期以及病患年纪有所不同。为此,AME出版社邀请上海复旦大学附属肿瘤医院乳腺外科的邵志敏教授与美国 Memorial Sloan-Kettering Cancer Center 的 Peter G. Cordeiro 教授、 University of Texas MD Anderson Cancer Center 的 Charles M Balch 教授共同担任主编出版了英文专著 Breast Cancer .

本书囊括了乳腺癌的流行病学、基础研究进展和成像检查等知识,进一步分析治疗乳腺癌常用的方法,例如,手术、内分泌、化疗、放疗靶向药物治疗等,并讨论了乳腺癌的预后和预防建议;鼓励广大的女性朋友,以及男性朋友多主动了解一些乳腺疾病的科普知识,掌握乳腺自我检查方法,防患于未然。AME将同步出版本书的中文版《乳腺癌》,现诚邀国内外该领域优秀医学工作者参与本书的翻译工作!

此专题待翻译文章目录如下,欢迎各位认领:

编号

文章题目

1

Lack of patient-reported outcomes assessment in phase III breast cancer studies: a missed opportunity for informed decision making

2

An update on the genomic landscape of breast cancer: new opportunity for personalized therapy?

3

Towards the elucidation of the mechanisms underlying breast cancer mutations

4

Members of the BRCA1 complexes as new susceptibility genes for breast cancer

5

APOBEC3B spreads somatic mutations in breast cancer genome

6

From genomic data analysis to drug development: a new generation of trials using molecular marker assessment in breast cancer

7

MET deregulation in breast cancer

8

Circulating free DNA in the management of breast cancer

9

Conservative mastectomies for breast cancer and risk-reducing surgery: the Memorial Sloan Kettering Cancer Center experience

10

Surgical management of breast cancer in China: the Fudan University Shanghai Cancer Center experience

11

Paradigm of polyendocrine therapy in endocrine responsive breast cancer: the role of fulvestrant

12

A balancing act for breast cancer? Everolimus for hormone receptor positive patients

13

Neoadjuvant bevacizumab and chemotherapy in breast cancer

14

Impact of preoperative magnetic resonance imaging in breast cancer patients candidates for an intraoperative partial breast irradiation

15

First year experience with IORT for breast cancer at the Geneva University Hospitals

16

CyberKnife stereotactic body radiotherapy and CyberKnife accelerated partial breast irradiation for the treatment of early breast cancer

17

Brest experience in intraoperative radiotherapy for breast cancer

18

Intraoperative radiotherapy with electrons (ELIOT) for early breast cancer: the European Institute of Oncology experience

19

Comparison of the proliferative and clonogenic growth capacity of wound uid from breast cancer patients treated with and without intraoperative radiotherapy

20

The use of postoperative radiation after nipple sparing mastectomy

21

Optimal management of sentinel lymph node positive biopsy patients in early breast cancer

22

Should trastuzumab be administered concomitantly with anthracycline in women with early, HER2-positive breast cancer?

23

Pertuzumab in metastatic breast cancer: unanswered questions

24

Pertuzumab: a step forward in treating HER2-positive breast cancer

25

Bevacizumab: Where do we go from here in breast cancer?

26

Lapatinib as a therapeutic option in brain metastases from HER2+ breast cancer

27

The ALTERNATE trial: assessing a biomarker driven strategy for the treatment of post- menopausal women with ER+/Her2− invasive breast cancer

28

Theranostic nanoparticles for enzyme-activatable uorescence imaging and photodynamic/chemo dual therapy of triple-negative breast cancer

29

Breast cancer and sleep disturbance: more than simply a quality of life concern

30

Brain metastases in HER2 positive breast cancer: the next hurdle

31

Brain metastases in HER2-positive breast cancer: challenges and opportunities

主编风采:

邵志敏

1985年毕业于上海医科大学,1990年毕业于上海医科大学研究生院获肿瘤学硕士。自1995年起,一直在复旦大学附属肿瘤医院工作,1998年晋升为教授,并被批准为博士生导师。首批教育部长江学者特聘教授,复旦特聘教授。现任复旦大学肿瘤研究所长、乳腺癌研究所所长,大外科主任兼乳腺外科主任,中国抗癌协会乳腺癌专业委员会名誉主委,中华医学会肿瘤学分会副主任委员,上海市抗癌协会乳腺癌专业委员会名誉主任委员,上海市医学会肿瘤专科委员会主任委员,第八届亚洲乳腺癌协会主席、St.Gallen乳腺癌大会专家团成员。主要从事乳腺癌的临床和基础研究,建立适合中国人群的早期筛查和诊疗流程,开展临床试验提高乳腺癌患者的预后,科研重点为乳腺癌的转化研究和乳腺癌转移机制研究等。已发表有关乳腺癌研究的论著近350篇,其中SCI收录100余篇,被世界医学文献引用逾3000次,主编专著4本。

Peter G. Cordeiro, MD, FACS

Dr. Cordeiro is a leader in the area of oncologic reconstructive surgery at a national and international level. He served as Chief of the Plastic and Reconstructive Surgical Service at Memorial Sloan Kettering for 15 years. During this time he oversaw the clinical and research activities of the service as well as the fellowship training program in breast reconstruction and microsurgery.

Charles M. Balch, M.D.

Department of Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA. Dr. Balch leads a distinguished career as a surgical oncologist and authority in melanoma and breast cancer. He has authored over 630 publications on topics such as clinical investigations involving the natural history of melanoma, prognostic factors predicting clinical outcomes, standards of surgical treatment, and the conduct and methodology of clinical research and immunology. He is regarded as one of the leading melanoma experts in the world.

AME科研时间系列图书

AME推出的本系列图书,将临床、科研、人文三者有机结合到一起,像西餐一样,烹调出丰富的味道,搭配出一道精美的佳肴呈现给各位。

comments powered by Disqus

附件